Professor Claude M. Wischik, co-founder and Executive Chairman of TauRx Therapeutics, along with colleagues at the University of Aberdeen, has devoted nearly 30 years to investigating the structure and role of tau tangles in the development of Alzheimer’s, frontotemporal dementia and other neurodegenerative diseases. Prof. Wischik discovered that the neurofibrillary tangles seen in Alzheimer’s disease are made of sub-units of the tau protein and he and his team have published extensively in the field.
Filter by yearAll 2022 2021 2020 2019 2018 2017 2016 2015 2014 2012 2011 2010 2009 2008 2007 2006 2005 2001 2000 1998 1997 1996 1995 1994 1993 1992 1991 1990 1988 1986 1985
Al-Hilaly, Y.K., et al. (2017) Alzheimer's disease-like paired helical filament assembly from truncated tau protein is independent of disulphide cross-linking. Available at: Journal of Molecular Biology
Miguel Angel Ontiveros-Torres, et al. (2017) Carboxy-Terminus Tau Protein Hyperphosphorylation is Associated with Extracellular Deposits of Amyloid-β Fibrillary in a Triple-Transgenic Model of Alzheimer’s Disease. Available at Journal of Neurological Disorders
Schwab, K, et al. (2017) LMTM DECREASES α-SYNUCLEIN PATHOLOGY AND REDUCES BEHAVIOURAL DEFECTS IN α-SYNUCLEIN TRANSGENIC MICE. Available at: Alzheimer's and Dementia.
Shiells, H, et al. (2017) The effect of latent confounding processes on the estimation of the strength of causal influences in chain-type networks. Available at: Medical Research Archives.
Šimić, G, et al. (2017) Monoaminergic Neuropathology in Alzheimer's disease. Available at: Progress in Neurobiology.